Improvement of Survival over Time for Colorectal Cancer Patients: A Population-Based Study

被引:26
作者
Dulskas, Audrius [1 ,2 ]
Gaizauskas, Vytautas [3 ]
Kildusiene, Inga [4 ]
Samalavicius, Narimantas Evaldas [2 ,5 ,6 ]
Smailyte, Giedre [4 ,7 ]
机构
[1] Natl Canc Inst, Dept Abdominal & Gen Surg & Oncol, 1 Santariskiu Str, LT-08406 Vilnius, Lithuania
[2] Vilnius Univ, Fac Med, Inst Clin Med, LT-03101 Vilnius, Lithuania
[3] Vilnius Univ Hosp, Dept Abdominal Surg, Santaros Clin, 2 Santariskiu Str, LT-08661 Vilnius, Lithuania
[4] Natl Canc Inst, Lab Canc Epidemiol, LT-08406 Vilnius, Lithuania
[5] Klaipeda Univ Hosp, Dept Surg, 41 Liepojos Str, LT-92288 Klaipeda, Lithuania
[6] Klaipeda Univ, Hlth Res & Innovat Sci Ctr, Fac Hlth Sci, 84 Herkaus Manto Str, LT-92294 Klaipeda, Lithuania
[7] Vilnius Univ, Fac Med, Inst Hlth Sci, LT-03101 Vilnius, Lithuania
关键词
colorectal cancer; colorectal cancer survival; national burden; Lithuanian cancer registry; III COLON-CANCER; STAGE-II; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; EXCISION; TRENDS;
D O I
10.3390/jcm9124038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: In this study, we analyzed the mortality and survival of colorectal cancer patients in Lithuania. Methods: This was a national cohort study. Population-based data from the Lithuanian Cancer Registry and period analyses were collected. Overall, 20,980 colorectal cancer patients were included. We examined the changes in colorectal cancer mortality and survival rates between 1998 and 2012 according to cancer anatomical sub-sites and stages. We calculated the 5-year relative survival estimates using period analysis. Results: Overall, 20,980 colorectal cancer cases reported from 1998 to 2012 were included in the study. The total number of newly diagnosed colorectal cancers increased from 1998-2002 to 2008-2012 by 12.1%. The highest number of colorectal cancers was localized and increased from 33.9% to 42.0%. The number of cancers with regional metastases and advanced cancers decreased by 11.1% and 15.5%, respectively. An increased number of new cases was observed for almost all colon cancer sub-sites. The overall 5-year relative survival rate increased from 37.9% in 1998-2002 to 51.5% in 2008-2012. We showed an increase in survival rates for all stages and all sub-sites. In the most recent period, patients with a localized disease had a 5-year survival rate of 78.6%, while survival estimates for advanced cancer patients remained low at 6.6%. Conclusion: Although survival rates variated in colorectal cancer patients according to disease stages and sub-sites, we showed increased survival rates for all patients.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 31 条
  • [1] Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
    Allemani, Claudia
    Weir, Hannah K.
    Carreira, Helena
    Harewood, Rhea
    Spika, Devon
    Wang, Xiao-Si
    Bannon, Finian
    Ahn, Jane V.
    Johnson, Christopher J.
    Bonaventure, Audrey
    Marcos-Gragera, Rafael
    Stiller, Charles
    Azevedo e Silva, Gulnar
    Chen, Wan-Qing
    Ogunbiyi, Olufemi J.
    Rachet, Bernard
    Soeberg, Matthew J.
    You, Hui
    Matsuda, Tomohiro
    Bielska-Lasota, Magdalena
    Storm, Hans
    Tucker, Thomas C.
    Coleman, Michel P.
    [J]. LANCET, 2015, 385 (9972) : 977 - 1010
  • [2] American Cancer Society, SURV RAT COL CANC
  • [3] Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study
    Andre, Thierry
    de Gramont, Armand
    Vernerey, Dewi
    Chibaudel, Benoist
    Bonnetain, Franck
    Tijeras-Raballand, Annemilai
    Scriva, Aurelie
    Hickish, Tamas
    Tabernero, Josep
    Van Laethem, Jean Luc
    Banzi, Maria
    Maartense, Eduard
    Shmueli, Einat
    Carlsson, Goran U.
    Scheithauer, Werner
    Papamichael, Demetris
    Moeehler, Marcus
    Landolfi, Stefania
    Demetter, Pieter
    Colote, Soudhir
    Tournigand, Christophe
    Louvet, Christophe
    Duval, Alex
    Flejou, Jean-Francois
    de Gramont, Aimery
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (35) : 4176 - +
  • [4] Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
    Andre, Thierry
    Boni, Corrado
    Navarro, Matilde
    Tabernero, Josep
    Hickish, Tamas
    Topham, Clare
    Bonetti, Andrea
    Clingan, Philip
    Bridgewater, John
    Rivera, Fernando
    de Gramont, Aimery
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3109 - 3116
  • [5] [Anonymous], 2018, CANC TODAY
  • [6] Global patterns and trends in colorectal cancer incidence and mortality
    Arnold, Melina
    Sierra, Monica S.
    Laversanne, Mathieu
    Soerjomataram, Isabelle
    Jemal, Ahmedin
    Bray, Freddie
    [J]. GUT, 2017, 66 (04) : 683 - 691
  • [7] Comparative cancer survival information in Europe
    Berrino, Franco
    Verdecchia, Arduino
    Lutz, Jean Michel
    Lombardo, Claudio
    Micheli, Andrea
    Capocaccia, Riccardo
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (06) : 901 - 908
  • [8] Bierley JD., 2017, TNM classification of malignant tumors, V8th
  • [9] Volume-outcome analysis of colorectal cancer-related outcomes
    Borowski, D. W.
    Bradburn, D. M.
    Mills, S. J.
    Bharathan, B.
    Wilson, R. G.
    Ratcliffe, A. A.
    Kelly, S. B.
    [J]. BRITISH JOURNAL OF SURGERY, 2010, 97 (09) : 1416 - 1430
  • [10] Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer
    Braendengen, Morten
    Tveit, Kjell M.
    Berglund, Ake
    Birkemeyer, Elke
    Frykholm, Gunilla
    Pahlman, Lars
    Wiig, Johan N.
    Bystrom, Per
    Bujko, Krzysztof
    Glimelius, Bengt
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) : 3687 - 3694